Evaluation of in vitro activity of a new fluoroquinolone trovafloxacin (cp-99,219) compared with other anti-anaerobic antimicrobials against members of the Bacteroides fragilis group (Q81605912)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 May 1997

Language	Label	Description	Also known as
English	Evaluation of in vitro activity of a new fluoroquinolone trovafloxacin (cp-99,219) compared with other anti-anaerobic antimicrobials against members of the Bacteroides fragilis group	scientific article published on 01 May 1997

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611810%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Evaluation of in vitro activity of a new fluoroquinolone trovafloxacin (cp-99,219) compared with other anti-anaerobic antimicrobials against members of the Bacteroides fragilis group (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611810%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Bacteroides fragilis

object named as

Bacteroides fragilis

1 reference

based on heuristic

inferred from title

author name string

M V Borobio

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611810%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

A I Suárez

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611810%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

E Ramírez

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611810%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

E J Perea

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611810%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 May 1997

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611810%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

International Journal of Antimicrobial Agents

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611810%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611810%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611810%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

249-252

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611810%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900014-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibilities of 540 anaerobic gram-negative bacilli to amoxicillin, amoxicillin-BRL 42715, amoxicillin-clavulanate, temafloxacin, and clindamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900014-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative activities of eight quinolones against members of the Bacteroides fragilis group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900014-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of two methods for rapid testing for beta-lactamase production in Bacteroides and Fusobacterium.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900014-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900014-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Methods of measuring susceptibility of anaerobic bacteria to trovafloxacin, including quality control parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900014-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900014-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900014-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900014-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Survey of Bacteroides fragilis group susceptibility patterns in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900014-9

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900014-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900014-9

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activities of three of the newer quinolones against anaerobic bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900014-9

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900014-9

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900014-9

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900014-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0924-8579(97)00014-9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611810%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611810%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81605912&oldid=1806665184"